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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S424trials was modest (mean Jadad score ¼ 2.08). All studies reported a
positive association between 2 to 5 weeks of Herbal Medicated-Bath
Therapy and improved clinical pain symptoms compared with non-
steroidal anti-inﬂammatory analgesics or hyaluronate injection con-
trols. Mild adverse events were reported in both groups. Discordant trial
designs, lack of reported sufﬁcient qualitative outcome measures and
other methodological limitations precluded a pooled meta-analysis.
Conclusions: These studies suggest that Chinese Herbal Medicated
Bath Therapy may be helpful in the treatment of pain symptoms in
patients with KOA; however, most studies aremodest in quality. Further
rigorously designed and well-controlled RCTs are warranted.Table 1
Lipidomic proﬁles of OA articular cartilage in response to mTOR regulation
m/z peak Lipid assignment Designation Condition
104 Choline [M+H]+ Rapamycin
184 Phosphocholine [M+H]+ Rapamycin
2 Palmitoleamide [M+H]+ Control
285 Stearic acid [M+H]+ Rapamycin
304,2 Arachidonic acid [M+H]+ Control
522,6 Phosphocholine (18:1) [M+H]+ Rapamycin
582,3 Rapamycin Rapamycin
666,4 From m/z Sphingomyelin [M+Na]+ Rapamycin
725,4 Sphingomyelin [M+Na]+ Rapamycin
936,5 Rapamycin [M+Na]+ RapamycinProteomics & Metabolomics
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THE MAMMALIAN TARGET OF RAPAMYCIN REGULATES LIPID
METABOLISM IN OSTEOARTHRITIC HUMAN ARTICULAR CARTILAGE
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P. Filgueira-Fernandez z, N. Goyanes z, R.A. Heeren y, F.J. Blanco z,
B. Carames z. y FOM Inst. AMOLF, Amsterdam, Netherlands; zOsteoarticular
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Purpose: There is increasing evidence indicating that lipid accumu-
lation increases with aging and OA, perhaps contributing to the chon-
drocyte dysfunction. The mammalian target of rapamycin (mTOR) is a
conserved serine-threonine kinase that regulates cell growth, cellular
proliferation and metabolism in response to nutrient signals. In fact, it
has been demonstrated that mTOR mediates in the onset and pro-
gression of diabetes, cancer and ageing process. However, the speciﬁc
involvement of mTOR in the regulation of lipid metabolism in articular
cartilage is poorly understood. The objective of this study is to deter-
mine the effect of mTOR inhibition in the regulation of the lipid
metabolism in human articular cartilage.
Methods: OA cartilage slices were treated with mTORC1 selective
inhibitor Rapamycin (Rapa, 10 mM), mTORC1 and mTORC2 inhibitor
Torin 1 (75 nM), as well as with a limited medium under tissue star-
vation conditions (Hank’s Balance Salt solution, HBSS) for 24 hours. Oil
Red and Nile blue stainings were performed to analyze the effect of
mTOR inhibitors on lipidic species present in OA articular cartilage.
Matrix Assisted Laser Desorption Ionization Mass Spectrometry Imag-
ing (MALDI-MSI) was used to study the differential lipidomic proﬁles
under all conditions. Samples were sectioned in triplicate in 10 mm thick
sections. 2,5-dihydroxybenzoic acid (DHB) matrix at 20 mg/mL in 20
mg/mL MeOH:AcN (50:50) was deposited by a vibrational sprayer
system. A Synapt HDMS MALDI-Q-TOF instrument was used to perform
the imaging-MS and MS/MS experiments with a spatial raster size of
150 mm. Principal Component Analysis (PCA) and Discriminant Analysis
(DA) were used to build regional molecular classiﬁers. Biomap software
was used to visualize molecular distributions. The Lipid Maps database
was used for lipid identiﬁcation.
Results: Lipid histological staining demonstrate that the inhibition of
mTOR dramatically decreases the lipid pool positive staining in OA
articular cartilage, indicating a direct regulation of lipid dynamics by
both pharmacological and physiological regulation of mTOR. However,
the histological analysis was insufﬁcient to detect and identify speciﬁc
lipid species. We employed a MALDI-MSI analysis to extend our
understanding of these processes. PCA and DA revealed different lip-
idomic proﬁles among control, rapamycin, torin and starvation con-
ditions. Firstly, we analyzed the four conditions in a single dataset
where the ﬁrst discriminant function (DF1) clearly separated the
nutrient depleted tissue from the other groups. DF2 predominantly
distinguished between control and rapamycin treated tissue. DA
revealed that Palmitoleamide and Arachidonic acid were increased in
the control condition whereas Phosphocholine and Sphingomyelin
related peaks were speciﬁc from rapamycin condition (Table 1). In
addition, rapamycin fragments were found in the treated samples of
this drug such as m/z 582.3 and m/z 936.5 demonstrating the capability
of the technique to study the lipid metabolism in addition to drug
metabolism in the cartilage.Conclusions: The MSI analysis data indicates that the mTOR regulates
the lipid proﬁle of human OA cartilage. The palmitoleamide and
arachidonic acid, the lipid species identiﬁed on control condition had
been implicated in the aging process and in the regulation of inﬂam-
matory mediators, such as leukotrienes and prostaglandins, respec-
tively. Interestingly, rapamycin treatment modiﬁed the lipid proﬁle to
choline, phosphocholine or sphingomyelin, all implicated to maintain
the cellular membrane integrity. In summary, these results demonstrate
that MALDI-MSI analysis is a useful tool in the study of lipid and ele-
mental composition changes associated with rheumatic pathologies
and exhibit outstanding diagnostic potential.765
QUANTITATIVE PROTEOMIC ANALYSIS REVEALED DIFFERENTIALLY
EXTRACELLULAR PROTEIN PROFILES OF OSTEOARTHRITIC AND
NORMAL MESENCHYMAL STEM CELLS UNDERGOING
CHONDROGENESIS
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P. Fernandez-Puente y, J. Mateos y, M. Carrascal z, C. Ruiz-Romero y,x,
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Purpose: Chondrogenesis occurs as a result of mesenchymal stem cells
(MSCs) condensation and chondroprogenitor cell differentiation. Fol-
lowing chondrogenesis, the chondrocytes remain as resting cells to
form the articular cartilage. A major challenge for the osteoarthitic (OA)
cartilage reparation by stem cell-based approaches is the under-
standing of this multi-step process. In this work, we have analyzed the
extracellular protein expression proﬁle of human bone marrow MSCs
(hBMSCs) of osteoarthritic patients and control donors undergoing
chondrogenesis, in order to compare the mechanisms involved in the
cartilage extracellular matrix (ECM) remodeling that occurs during the
chondrogenic differentiation process.
Methods: hBMSCs isolated from 3 OA patients and 3 healthy controls
were grownwith different isotope variants of lysine and arginine (Arg6,
Lys4 for the control population and Arg10, Lys8 for the OA population)
during 4-6 weeks, until achievement of full protein labeling. The labeled
populations were then subjected to differentiation in 3D cultures
(micromasses) supplemented with chondrogenic inducers for 14 days.
Proteins in the conditioned media from the two cell populations were
combined, separated by 1D-SDS-PAGE and subjected to in-gel trypsin
digestion using an automatic digestor. The resulting peptide mixtures
were analyzed by nanoLC coupled on-line to an LTQ-Orbitrap XL mass
spectrometer and quantiﬁed using the MaxQuant software and the
Perseus tool.
Results: Real-Time PCR assays showed a relevant difference in the gene
expression of collagen type II in the normal donors when compared to
the OA patients. Moreover, the chondrocyte phenotype was conﬁrmed
in both cases by the proteglycan immunostainings such as aggrecan and
chondroitin-6-sulfate after 14 days in chondrogenesis. Using the pro-
teomic approach, we compared the extracellular protein proﬁles of OA
and normal hBMSC at the same time of differentiation. Among the 531
proteins, 56 had signiﬁcantly altered levels. 35 proteins displayed
consistently higher levels in the OA samples compared to normal
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S425donors. Many of these proteins are cartilage speciﬁc proteoglycans such
as hyaluronan and proteoglycan link protein 1, aggrecan core protein or
lumican as well as some proteins with a well-known role in the
pathogenesis of OA like COMP or MMP3. On the other hand, 21 proteins
exhibited a signiﬁcantly reduced abundance in OA patients when
compared to controls. Interestingly, we detected several proteins which
belong to the tenascin protein family, like tenascin-X, which accelerates
collagen ﬁbril formation. We also found WISP2 decreased at day 14,
suggesting a lower activity of the Wnt signaling pathway in OA cells.
Conclusions: The identiﬁcation and quantiﬁcation of these secreted
proteins enhance our knowledge on the extracellular regulation of the
chondrogenesis and allow the identiﬁcation of extracellular markers of
this process. Moreover, the lower expression of some of them in OA
patients (like tenascin-X or WISP2), suggest their putative usefulness
for the molecular monitorization of the chondrogenesis in cell therapy-
based approaches for cartilage repair.
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A LIPIDOMIC STUDY OF SPHINGOLIPID SPECIES IN HUMAN
SYNOVIAL FLUID
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Purpose: Articular synovial ﬂuid (SF) is a complex mixture of compo-
nents either derived from plasma or locally synthesized by synovial
tissues, which are involved in nutrition, communication, shock
absorption, and lubrication. Alterations in its composition can be
associated with increased friction, leading to articular cartilage damage,
or with changes in inﬂammatory status of synovial joints. We already
quantiﬁed 130 phospholipid species in human osteoarthritis (OA) and
rheumatoid arthritis (RA) SF. The presented lipidomic investigation
aims to quantify for the ﬁrst time, the composition of sphingolipids
[sphingomyelins (SM), ceramides (Cer), hexosylceramides (HexCer) and
dihexosylceramides (Hex2Cer) species] in the SF of knee joints from
unaffected controls, patients with early (eOA) and late (lOA) stages of
OA and from RA patients, and to further elucidate whether the con-
centrations of individual lipid species are associated with the stage of
OA disease.
Methods: According to predeﬁned inclusion and exclusion criteria
patients were included in the study. The use of human SF for this study
was approved by the local ethics committee of our university, and all
participants provided written informed consent. Lipids were extracted
from SF without cells and cellular debris from 9 postmortem donors
(control), 18 RA, and 30 OA patients. OA group was subcategorized as
early (n ¼ 17) and late (n ¼ 13) using Outerbridge score. RA patients
were classiﬁed according to the criteria of the American College of
Rheumatology. Lipids were quantiﬁed using electrospray ionization
tandem mass spectrometry - directly or coupled with hydrophilic
interaction liquid chromatography. The quantitative values of all lipid
species were corrected by the method described by Kraus et al. (2002).
The Kruskal-Wallis test adjusted with a false discovery rate (FDR) of 10%
and the Wilcoxon rank sum test were applied to determine statistically
signiﬁcant differences. P values < 0.05 were considered to be statisti-
cally signiﬁcant.
Results: We provide a novel, detailed overview of sphingolipid species
in human SF. The analytical set-up used in the present study allowed us
to quantitate 35 different sphingolipid species. We identiﬁed 19 SM
species, based on the length and saturation of the attached fatty acids.
SM 34:1 was the predominant species among SMs. In addition, versus
control SF, all species were elevated in eOA, lOA and RA SF. Remarkably,
all SM species rose approximately 2-fold in SF from eOA to lOA and
approximately 1.5-fold in SF from eOA to RA. However, we found no
signiﬁcant different levels of SM species in lOA compared with RA SF.
Also, 6 Cer, 5 HexCer and 5 Hex2Cer were identiﬁed in human SF. Cer
d18:0/24 was the predominant species. Moreover, most Cer species
contained saturated fatty acids in all cohorts. Compared to control SF,
the levels of most Cer species were 4.5-fold higher in lOA and 5.8-fold in
RA SF. Moreover, all Cer species rose approximately 1.7-fold in SF from
eOA to RA, and nearly 1.3-fold in SF from lOA to RA.
Conclusions: This lipidomic investigation present for the ﬁrst time a
detailed overview of sphingolipid species in human SF. Compared to
control SF the concentrations of sphingolipid species such as SM andCer were found to be elevated in eOA, lOA and RA SF. Since, disease and
stage-dependent differences in the composition and concentrations of
lipid species might result not only in an impaired lubrication but also in
an altered inﬂammatory status of joints, sphingolipids appear to be
associated with the pathogenesis of OA and RA. Our study lays the
foundation for addressing speciﬁc questions regarding the biosynthesis
and function of sphingolipid species in SF.
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IDENTIFICATION OF AUTOANTIBODIES IN SERUM FROM
OSTEOARTHRITIS PATIENTS USING MICROARRAYS
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Purpose: Osteoarthritis (OA) is characterized by the loss of structural
components from the extracelullar matrix (ECM) of articular cartilage.
The progressive release of proteins from the tissue and an abnormal
metabolic activity can be speciﬁcally detected by the immune system,
leading to a humoral immune response producing immunoglobulins
against these proteins (autoantibodies). Autoantibodies are stable cir-
culating proteins, easily measurable in serum, and may be the signature
before clinical manifestations of the disease. Protein microarrays have
emerged providing a tool for the identiﬁcation of disease immuno-
signatures. The aim of this study was to detect the presence of auto-
antibodies in OA serum samples and compare these results with those
obtained from healthy (CTRL) and rheumatoid arthritis (RA) sera.
Methods: Antibodies were detected using an speciﬁc Nucleic Acid
Protein Programmable Array (NAPPA) designed and constructed as
previously described by Ramachandran et al. 2008, containing 80
sequence-veriﬁed full-length human genes obtained from the Center
for Personalized Diagnostics at the Arizona State University (www.
dnasu.org). Once protein was displayed by in situ protein expression
system, NAPPA arrays were incubated in optimized conditions with 20
OA, 20 RA and 18 CTRL serum samples. The autoantibodies were
detected by anti-human IgG-HRP and ﬂuorescence dye. Array images
were obtained and processed by Genepix4000B and GenePix Software
6.0. For data analysis, background correction was performed by sub-
traction of the ﬁrst quartile of non-DNA spots intensity and then divided
the excess intensity by the median of spots without DNA across arrays.
Results: Signiﬁcantly (p< 0.05) 4 different expression of autoantibodies
against four different proteins has been observed between OA and CTRL
serum samples. Of note, 2 of these proteins are related to the metabo-
lism of ECM; the others are associated to cell adhesion (1) and bone
mineralization (1). Most interestingly, this approach allowed the dif-
ferential classiﬁcation of RA and OA patients by the detection of 3
speciﬁc autoantibodies against proteins involved in cell proliferation
and bone mineralization processes; one of these proteins also dis-
tinguishing between CTRL and RA subjects.
Conclusions: We have identiﬁed the presence of speciﬁc autoanti-
bodies in OA allowing to distinguish between OA and CTRL patients and
most interestingly, between OA and RA patients. These autoantibodies
released to the serum might have a biomarker value to more accurate
early diagnosis and prognosis of OA patients in clinical routine.
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PEPTIDES PROFILING OF CARTILAGE SECRETOME: A PROMISING
ALTERNATIVE FOR OA BIOMARKER DISCOVERY
V. Calamia, L. Lourido, J. Mateos, P. Fernandez-Puente, C. Fernandez,
B. Rocha, F.J. Blanco, C. Ruiz-Romero. Rheumatology Div., Proteomics
Group-ProteoRed/ISCIII, INIBIC-CHUAC, A Coru~na, Spain
Purpose: The low-molecular-weight subset of the cartilage proteome
(also termed cartilage peptidome) may have a diagnostic potential in
osteoarthritis (OA) research, not yet fully exploited. The aim of this
study is to investigate the cartilage secretome by means of peptidomic
analysis and to provide a novel source for OA biomarker discovery.
Methods: Tissue explants were obtained from the dissection of human
OA cartilages, both from the unwounded zone (UZ) and the wounded
zone (WZ). The study was approved by the local ethical committee.
Cartilage shavings from each zone were cut into 6 mm discs and ﬁve
